Skip to main content

Rivastigmine Tartrate

NDC 65862-649 · Aurobindo Pharma Limited

Generic nameRivastigmine Tartrate
Dosage formCAPSULE
RouteORAL
Active ingredient(s)RIVASTIGMINE TARTRATE
Strength3 mg/1
Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
Marketing categoryANDA

Packages

65862-649-05 — 500 CAPSULE in 1 BOTTLE (65862-649-05)

65862-649-60 — 60 CAPSULE in 1 BOTTLE (65862-649-60)

65862-649-78 — 10 BLISTER PACK in 1 CARTON (65862-649-78) / 10 CAPSULE in 1 BLISTER PACK (65862-649-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62135-903 — Rivastigmine Tartrate, 62332-063 — Rivastigmine Tartrate, 62332-064 — Rivastigmine Tartrate, 62332-065 — Rivastigmine Tartrate, 62332-066 — Rivastigmine Tartrate, 62756-145 — Rivastigmine Tartrate, 62756-146 — Rivastigmine Tartrate, 62756-147 — Rivastigmine Tartrate, 62756-148 — Rivastigmine Tartrate, 65862-648 — Rivastigmine Tartrate, 65862-650 — Rivastigmine Tartrate, 65862-651 — Rivastigmine Tartrate, 71209-012 — Rivastigmine Tartrate, 71209-013 — Rivastigmine Tartrate, 71209-014 — Rivastigmine Tartrate, 71209-015 — Rivastigmine Tartrate, 72241-011 — Rivastigmine Tartrate, 72241-012 — Rivastigmine Tartrate, 72241-013 — Rivastigmine Tartrate, 72241-014 — Rivastigmine Tartrate, +21 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.